Abstract:Objective To investigate diagnostic value of liver fibrosis for detecting the serum indicators of hyaluronic acid(HA), laminin(LN), procollagen Ⅲ N-terminal peptide (PⅢNP) and collagen type Ⅳ(CⅣ)with domestic chemical luminescence (CL) reagent. Methods Serum indicators of HA, LN, PⅢNP and CⅣwere detected with CL reagent in 123 cases of chronic hepatitis patients by pathological diagnosis(case group) and 30 healthy control(control group). Case group were divided into S0~S4 stages and diagnostic value was evaluated. Results It showed that the HA、LN、CIV in the case group were significantly higher than in control group[(4.47±0.86) vs. (2.02±0.23), P = 0.000;(4.15±0.81) vs. (3.57±0.67), P = 0.002; (3.49±0.89) vs. (2.15±0.81), P = 0.000]. All of the four serum indicators showed control group S0, S1 S2, S2 S3, HA and CⅣ dropped, LN and PⅢNP rose in S4 phage. There was statistically significance of four serum indicators in different liver fibrosis stages (P 0.01). It showed that there was significant difference between S0 and S2 group, S1 and S2 group (P 0.05). The other 3 indicators except HA were significantly correlated with fibrosis stage (P 0.01). Areas under receiver operating characteristic(ROC)curve (AUC) for diagnosis of liver fibrosis were CⅣ(0.790)HA(0.775) LN(0.725)PⅢNP(0.644), successively. Multiple serum indicators showed high sensitivity and accuracy of HA , three combination of HA+LN+CⅣand four indicators combination in diagnosis of liver fibrosis. Comprehensive diagnosis efficiency was CⅣLNPⅢNP. Positive likelihood ratio of single to combination detection was 1~3. Conclusions The four indicators have certain value for diagnosis of liver fibrosis, however, it is limited in diagnosis of early liver fibrosis. It has prominent significance in fibrosis S2 stage. With aggravation of liver fibrosis, HA and CⅣ reversely decline. It may be related with decomposition and reduction of extracellular matrix. It is suitable for application of multi-indicator combination to exclude liver fibrosis. Positive likelihood ratio of all single and combination detection to diagnose liver fibrosis is much lower. It indicates limited diagnosis value and can't substitute liver biopsy.

Application value of combined detection of serum total bile acid and liver function enzymes in clinical diagnosis of liver diseases

Correlation of serum total bile acid levels with liver tissue inflammation grade in chronic liver diseases

Clinical Significance and Detection of IL-18 in the Chronic Patients with HBV Infection

Significance of Combined Determination of Five Types of Serum Enzyme in Diagnosis and Differential Diagnosis of Hepatic and Biliary Diseases

Ratio Of Conjugated Chenodeoxycholic To Muricholic Acids Is Associated With Severity Of Nonalcoholic Steatohepatitis

The Value of Ultrasonic Elastographic Parameters in the Evaluation of Chronic Hepatitis B Liver Fibrosis

A Serum Metabolomic Analysis for Diagnosis and Biomarker Discovery of Primary Biliary Cirrhosis and Autoimmune Hepatitis.

The Clinical Significance of the Change of Blood-Lipid in Patients with Hepatitis B-related Cirrhosis.

[The Diagnostic Value of Eight Serum Indices for Liver Fibrosis].

Clinical Significance of Combined Detection of HBV DNA,PreS1 and ALT in Patients with Hepatitis B

Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B.

Serum metabolomic signatures discriminate early liver inflammation and fibrosis stages in patients with chronic hepatitis B

Application Analysis on Detection of Four Serum Indicators with a Domestic Chemiluminescence Reagent in Liver Fibrosis Diagnosis

The Clinical Significance of Up-Converting Phosphor Immunochromatography in Detecting Hepatitis B Virus Large Envelope Protein in Various Types of Chronic Liver Disease

Value of Analysis of Bilirubin in Bile in Predicting Liver Function in Early Stage after Liver Transplantation

Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis

Value of combined detection of four tumor markers in the diagnosis of primary hepatic cancer

The Diagnostic Value of Contrast-Enhanced Ultrasound and Enhanced CT Combined with Tumor Markers AFP and CA199 in Liver Cancer

Complementary Laboratory Indices for Predicting the Disease Status of Patients with Hepatitis B Virus Infection

Evaluation of serum non-invasive methods for the diagnosis of liver fibrosis in patients with chronic hepatitis B virus infection

[Noninvasive Evaluation of Liver Fibrosis in Chronic Hepatitis B Patients].